4-tert-Butylcyclohexyl chloroformate CAS:42125-46-2
4-tert-Butylcyclohexyl chloroformate is primarily utilized in organic synthesis, where its unique functionality plays a crucial role in the protection of reactive groups. One of the main applications of this compound is in the protection of alcohols and amines during multi-step synthetic procedures. By converting these functional groups into their corresponding chloroformates, researchers can prevent unwanted reactions that may occur at these sites, allowing for greater control over the overall synthesis of target compounds. The chloroformate group is particularly advantageous because it can be easily converted back into the original alcohol or amine under mild conditions, ensuring the desired functional groups can be reinstated in the final product. This makes 4-tert-butylcyclohexyl chloroformate especially valuable in complex synthetic pathways, such as those required in the pharmaceutical industry, where the development of new drugs often involves multiple transformations and delicate reaction conditions. In addition to its protective applications, 4-tert-butylcyclohexyl chloroformate can also be used in the synthesis of carbamates through reactions with amines. Carbamate formation is important for creating various biologically active compounds, including pesticides and pharmaceuticals. This versatility further enhances the compound's utility in both medicinal chemistry and agrochemical applications. Moreover, the stability and solubility of 4-tert-butylcyclohexyl chloroformate in organic solvents make it suitable for various laboratory settings, aiding researchers in developing new methodologies and exploring innovative synthetic routes. However, due to the reactive nature of chloroformates, appropriate safety measures must be observed during handling and use.
Composition | C12H19ClO2. |
Assay | 99% |
Appearance | white powder |
CAS No. | 42125-46-2 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |